UY30760A1 - DERIVATIVES OF UREA AND DERIVATIVES OF SULFAMIDA IN QUALITY OF TAFIA INHIBITORS - Google Patents

DERIVATIVES OF UREA AND DERIVATIVES OF SULFAMIDA IN QUALITY OF TAFIA INHIBITORS

Info

Publication number
UY30760A1
UY30760A1 UY30760A UY30760A UY30760A1 UY 30760 A1 UY30760 A1 UY 30760A1 UY 30760 A UY30760 A UY 30760A UY 30760 A UY30760 A UY 30760A UY 30760 A1 UY30760 A1 UY 30760A1
Authority
UY
Uruguay
Prior art keywords
derivatives
urea
sulfamida
quality
tafia inhibitors
Prior art date
Application number
UY30760A
Other languages
Spanish (es)
Inventor
Dr Nis Halland
Andreas Evers
Wengard Czechtinsky
Mark Broenstrup
Dr Herman Schreuder
Dr Markus Follmann
Dr Christopher Kallus
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Priority to UY30760A priority Critical patent/UY30760A1/en
Publication of UY30760A1 publication Critical patent/UY30760A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

RESUMEN Derivados de urea y derivados de sulfamida en calidad de inhibidores de TAFIa La invencion se refiere a compuestos de formula I que son inhibidores del inhibidor de la fibronolisis activable por trombina activado. Los compuestos de la formula I son adecuados para fabricar medicamentos para la profilaxis, la prevencion secundaria y la terapia de uno o mas trastornos que están asociados con trombosis, embolismos, hipercoagulabilidad o cambios fibroticos.SUMMARY Urea derivatives and sulfonamide derivatives as TAFIa inhibitors The invention relates to compounds of formula I which are inhibitors of the activated thrombin activatable fibronolysis inhibitor. The compounds of formula I are suitable for manufacturing drugs for prophylaxis, secondary prevention and therapy of one or more disorders that are associated with thrombosis, embolisms, hypercoagulability or fibrotic changes.

UY30760A 2007-12-04 2007-12-04 DERIVATIVES OF UREA AND DERIVATIVES OF SULFAMIDA IN QUALITY OF TAFIA INHIBITORS UY30760A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY30760A UY30760A1 (en) 2007-12-04 2007-12-04 DERIVATIVES OF UREA AND DERIVATIVES OF SULFAMIDA IN QUALITY OF TAFIA INHIBITORS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY30760A UY30760A1 (en) 2007-12-04 2007-12-04 DERIVATIVES OF UREA AND DERIVATIVES OF SULFAMIDA IN QUALITY OF TAFIA INHIBITORS

Publications (1)

Publication Number Publication Date
UY30760A1 true UY30760A1 (en) 2008-07-31

Family

ID=39688895

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30760A UY30760A1 (en) 2007-12-04 2007-12-04 DERIVATIVES OF UREA AND DERIVATIVES OF SULFAMIDA IN QUALITY OF TAFIA INHIBITORS

Country Status (1)

Country Link
UY (1) UY30760A1 (en)

Similar Documents

Publication Publication Date Title
UY28868A1 (en) HETEROCICLILACÉTIC ACIDS AS TAFLA INHIBITORS.
DOP2010000363A (en) MACROCICLIC AND SULFAMIDE UREA DERIVATIVES AS TAFIA INHIBITORS
NI201100166A (en) BENZOFURANIL DERIVATIVES USED AS GLUCOKINASE INHIBITORS
NI201600058A (en) RING-FUSED BICYCLIC PYRIDYL-DERIVED COMPOUNDS AS FGFR4 INHIBITORS
CR20160170A (en) COMPLEMENT FACTOR MODULATORS B
PE20150631A1 (en) CRYSTALLINE FORMS OF AN ANDROGEN RECEPTOR MODULATOR
CO6761389A2 (en) Nampt and rock inhibitors
CU24397B1 (en) DERIVATIVES OF PIPERIDINIL-INDOL AS INHIBITORS OF THE COMPLEMENT FACTOR B
CL2018001996A1 (en) Compositions and methods to modulate the expression of complement factor b (divisional application 2764-16)
CR20110103A (en) HETEROARILOS SUBSTITUTED
UY34804A (en) NAMPT INHIBITORS
BR112012002134B8 (en) apaf-1 inhibitor compounds
CR10277A (en) PIRAZOLQUINOLONAS AS POWERFUL PARP INHIBITORS
HN2006018410A (en) NEW DERIVATIVES OF FLUORENE, COMPOSITIONS THAT CONTAIN THEM AND USE
ECSP14030779A (en) NAMPT INHIBITORS
CL2015002434A1 (en) Benzoimidazol-2-yl pyrimidines modulators of the histamine h4 receptor.
UY30627A1 (en) METALOPROTEASE INHIBITORS DERIVED FROM HETEROCICLES
HN2006015130A (en) ASSOCIATION BETWEEN RAILWAY AND AN ARTEMISINE DERIVATIVE FOR THE TREATMENT OF PALUDISM
NO20092246L (en) Urea and sulfamide derivatives as suppository inhibitors
UY30760A1 (en) DERIVATIVES OF UREA AND DERIVATIVES OF SULFAMIDA IN QUALITY OF TAFIA INHIBITORS
DOP2007000142A (en) UREA DERIVATIVES AND SULFAMIDA DERIVATIVES IN QUALITY OF TAFIA INHIBITORS
NI201000139A (en) ASSOCIATION OF A SINUS CURRENT INHIBITOR If AND A BETA-BLOCKER
RU2009104276A (en) ANTIULCEROGENIC PRODUCT
UY32215A (en) INHIBITORS OF THE S1P LIASA FOR THE TREATMENT OF CEREBRAL MALARIA
AR101915A1 (en) INTERMEDIARIES AND PROCESSES FOR THE PREPARATION OF COMPOUNDS

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20170906